SWOG clinical trial number
SWOG-8935
Evaluation of Continuous Infusion Interleukin-2 (IL-2) in Patients with Squamous Cell Carcinoma of the Head and Neck, Phase II
Closed
Phase
Accrual
14%
Abbreviated Title
Evaluation of Continuous Infusion Interleukin-2 (IL-2) in Patients with Squamous Cell Carcinoma of the Head and Neck, Phase II
Activated
11/15/1990
Closed
06/15/1992